Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Amgen USD 4.78B 1.12B 2026-03
Ardelyx USD 127.27M 7.15M 2026-03
aTyr Pharma USD 2.42M 83.19M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Curis USD 9.02M 23.01M 2025-12
Sanofi EUR 8.98B 1.73B 2026-03
TG Therapeutics USD 170.12M 28.04M 2026-03
United Therapeutics USD 5.9B 5.1B 2026-03